The conversations at SMFM 2026 reflected a specialty under pressure, but also in transition. Rising clinical complexity, uneven access to maternal-fetal medicine providers, and evolving workforce expectations are reshaping how high-risk obstetric care is delivered. The result is a clear shift toward distributed care models that blend on-site practice with telemedicine-enabled support.
Here are the shifts that stood out most clearly.
1. The future of maternal-fetal medicine is virtual
Access to maternal-fetal medicine expertise remains uneven nationwide. Many hospitals and clinics lack consistent on-site MFM coverage, particularly in rural and underserved regions. At SMFM’s 2026 Pregnancy Meeting, telemedicine was no longer framed as experimental. It is increasingly viewed as a practical, scalable component of high-acuity obstetric care.
While telehealth adoption in healthcare has historically faced hesitancy—often due to workflow, reimbursement, or quality concerns—advances in technology, integration, and clinical protocols are reshaping the conversation. The discussion is shifting toward how to implement telemedicine obstetrics thoughtfully, ensuring quality, collaboration, and continuity of care.
TeleMFM is becoming a structured extension of the maternal-fetal medicine toolkit: not a substitute for in-person care, but a strategic complement to it.
2. Remote monitoring is expanding what virtual MFM can deliver
Telehealth alone is not the full story. The growing ecosystem of remote monitoring tools is broadening the scope of what virtual maternal-fetal medicine can support.
From remote management of diabetes and hypertensive disorders to evolving approaches in fetal surveillance, technology is enabling elements of high-risk pregnancy care to occur closer to home. Specialist oversight can now be layered into care plans more continuously, rather than limited to isolated consults.
This evolution strengthens clinical oversight while reducing unnecessary travel and fragmentation—particularly for patients in communities without a local MFM center.
3. AI is entering the ultrasound workflow
Artificial intelligence in obstetric ultrasound has moved from theory to practical workflow enhancement. At the Pregnancy Meeting, the emphasis was clear: AI is not replacing clinical expertise. Instead, it is being positioned to support sonographers in image acquisition, reduce variability, and assist with interpretation.
For maternal-fetal medicine, where ultrasound is foundational, these tools may help standardize quality across diverse practice environments—especially in lower-volume or resource-constrained settings.
4. Workforce expectations are shaping care models
Maternal-fetal medicine is also responding to changing workforce realities. Flexibility, sustainability, and longevity are increasingly influencing how clinicians structure their careers. Hybrid models that incorporate telemedicine alongside on-site practice are gaining traction as a way to maintain clinical excellence while addressing burnout and recruitment challenges.
This shift has implications beyond staffing. It affects how access gaps are addressed nationwide.
5. Access and outcomes remain the mission
The throughline across these discussions is clear: the mission of maternal-fetal medicine remains improving outcomes for high-risk pregnancies. Technology, remote monitoring, and evolving workforce models are tools in service of that goal.
For hospitals and health systems, the question is no longer whether telemedicine can support high-acuity obstetrics, but how best to implement care models that expand access, protect quality, and deliver measurable clinical impact while working cooperatively with on-site care teams.
At Obtelecare, that mission—better access, stronger collaboration, and improved maternal and neonatal outcomes—remains central as the specialty moves into its next chapter.
